Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

471 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Danish phase II trial using adipose tissue derived mesenchymal stromal cells for patients with ischaemic heart failure.
Qayyum AA, Mouridsen M, Nilsson B, Gustafsson I, Schou M, Nielsen OW, Hove JD, Mathiasen AB, Jørgensen E, Helqvist S, Joshi FR, Johansen EM, Follin B, Juhl M, Højgaard LD, Haack-Sørensen M, Ekblond A, Kastrup J. Qayyum AA, et al. Among authors: kastrup j. ESC Heart Fail. 2023 Apr;10(2):1170-1183. doi: 10.1002/ehf2.14281. Epub 2023 Jan 13. ESC Heart Fail. 2023. PMID: 36638837 Free PMC article. Clinical Trial.
Intraglandular mesenchymal stem cell treatment induces changes in the salivary proteome of irradiated patients.
Lynggaard CD, Jersie-Christensen R, Juhl M, Jensen SB, Grønhøj C, Melchiors J, Jacobsen S, Møller-Hansen M, Herly M, Ekblond A, Kastrup J, Fischer-Nielsen A, Belstrøm D, von Buchwald C. Lynggaard CD, et al. Among authors: kastrup j. Commun Med (Lond). 2022 Dec 10;2(1):160. doi: 10.1038/s43856-022-00223-3. Commun Med (Lond). 2022. PMID: 36496530 Free PMC article.
Effect of allogeneic adipose tissue-derived mesenchymal stromal cell treatment in chronic ischaemic heart failure with reduced ejection fraction - the SCIENCE trial.
Qayyum AA, van Klarenbosch B, Frljak S, Cerar A, Poglajen G, Traxler-Weidenauer D, Nadrowski P, Paitazoglou C, Vrtovec B, Bergmann MW, Chamuleau SAJ, Wojakowski W, Gyöngyösi M, Kraaijeveld A, Hansen KS, Vrangbaek K, Jørgensen E, Helqvist S, Joshi FR, Johansen EM, Follin B, Juhl M, Højgaard LD, Mathiasen AB, Ekblond A, Haack-Sørensen M, Kastrup J; SCIENCE Investigators. Qayyum AA, et al. Among authors: kastrup j. Eur J Heart Fail. 2023 Apr;25(4):576-587. doi: 10.1002/ejhf.2772. Epub 2023 Jan 31. Eur J Heart Fail. 2023. PMID: 36644821 Free article. Clinical Trial.
Plasma Small Extracellular Vesicle Cardiac miRNA Expression in Patients with Ischemic Heart Failure, Randomized to Percutaneous Intramyocardial Treatment of Adipose Derived Stem Cells or Placebo: Subanalysis of the SCIENCE Study.
Traxler D, Dannenberg V, Zlabinger K, Gugerell A, Mester-Tonczar J, Lukovic D, Spannbauer A, Hasimbegovic E, Kastrup J, Gyöngyösi M. Traxler D, et al. Among authors: kastrup j. Int J Mol Sci. 2023 Jun 26;24(13):10647. doi: 10.3390/ijms241310647. Int J Mol Sci. 2023. PMID: 37445825 Free PMC article. Clinical Trial.
Effectiveness and safety of mesenchymal stem/stromal cell for radiation-induced hyposalivation and xerostomia in previous head and neck cancer patients (MESRIX-III): a study protocol for a single-centre, double-blinded, randomised, placebo-controlled, phase II study.
Jakobsen KK, Carlander AF, Grønhøj C, Todsen T, Melchiors J, Paaske N, Madsen AKØ, Kastrup J, Ekblond A, Haack-Sørensen M, Farhadi M, Maare C, Friborg J, Lynggard CD, von Buchwald C. Jakobsen KK, et al. Among authors: kastrup j. Trials. 2023 Sep 1;24(1):567. doi: 10.1186/s13063-023-07594-5. Trials. 2023. PMID: 37658468 Free PMC article.
Allogeneic mesenchymal stem cell therapy for dry eye disease in patients with Sjögren's syndrome: A randomized clinical trial.
Møller-Hansen M, Larsen AC, Wiencke AK, Terslev L, Siersma V, Andersen TT, Hansen AE, Bruunsgaard H, Haack-Sørensen M, Ekblond A, Kastrup J, Utheim TP, Heegaard S. Møller-Hansen M, et al. Among authors: kastrup j. Ocul Surf. 2024 Jan;31:1-8. doi: 10.1016/j.jtos.2023.11.007. Epub 2023 Dec 2. Ocul Surf. 2024. PMID: 38049032 Clinical Trial.
471 results